Blog

Writing from Sync-RX.

Notes on UK regulated digital health, GLP-1, peptides, and the infrastructure behind prescriber-gated commerce.

30 June 2026 · 5 minute read
The drug was never the whole answer
Oura and LillyDirect just made it official. The interesting part isn't the ring, it's who ends up owning the daily relationship with the patient.
Read post
29 June 2026 · 5 minute read
GPhC calls on pharmacies to strengthen safeguards in weight management services
The GPhC's April 2026 themed review sets a clear bar for pharmacies supplying weight management medicines. What it says, and what it means operationally.
Read post
20 June 2026 · 6 minute read
Peptides: the quiet boom reshaping modern medicine
A clear-headed look at the peptide boom: what peptides are, why demand is surging, the UK regulatory picture, and how brands can sell them safely.
Read post
20 June 2026 · 5 minute read
The GLP-1 tablet is coming: what UK pharmacies need to know
The oral GLP-1 is about to expand the UK weight loss market from 2.5 to 3.3 million patients. The commercial reality, and the operational shift for pharmacies.
Read post